Although MITF shRNA did not compromise tumor cell proliferation in vitro, we found many cancer-relevant genes to be regulated by MITF, including cell-surface and secreted factors repressing immune-mediated anti-tumor responses in triple-negative breast cancer (e.g. NT5E/CD73)38,39. This evidence concerns the gene NT5E and triple-negative breast carcinoma.